61. Reduced alpha diversity of the oral microbiome correlates with short progression‐free survival in patients with relapsed/refractory multiple myeloma treated with ixazomib‐based therapy (AGMT MM 1, phase II trial). Issue 1 (8th November 2020) Authors: Ludwig, Heinz; Hausmann, Bela; Schreder, Martin; Pönisch, Wolfram; Zojer, Niklas; Knop, Stefan; Gunsilius, Eberhard; Egle, Alexander; Petzer, Andreas; Einsele, Hermann; Hajek, Roman; Weisel, Katja; Krenosz, Karl Jochen; Lang, Alois; Lechner, Daniel; Greil, Richard; Berry, David Journal: EJHaem Issue: Volume 2:Issue 1(2021) Page Start: 99 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
62. Secondary plasma cell leukemia: a multicenter retrospective study of 101 patients. Issue 1 (2nd January 2019) Authors: Jurczyszyn, Artur; Castillo, Jorge J.; Avivi, Irit; Czepiel, Jacek; Davila, Julio; Vij, Ravi; Fiala, Mark A.; Gozzetti, Alessandro; Grząśko, Norbert; Milunovic, Vibor; Hus, Iwona; Mądry, Krzysztof; Waszczuk-Gajda, Anna; Usnarska-Zubkiewicz, Lidia; Dębski, Jakub; Atilla, Erden; Beksac, Meral; Mele... Journal: Leukemia & lymphoma Issue: Volume 60:Issue 1(2019) Page Start: 118 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
63. Selinexor, bortezomib, and dexamethasone versus bortezomib and dexamethasone in previously treated multiple myeloma: Outcomes by cytogenetic risk. Issue 9 (5th July 2021) Authors: Richard, Shambavi; Chari, Ajai; Delimpasi, Sosana; Simonova, Maryana; Spicka, Ivan; Pour, Ludek; Kriachok, Iryna; Dimopoulos, Meletios A.; Pylypenko, Halyna; Auner, Holger W.; Leleu, Xavier; Usenko, Ganna; Hajek, Roman; Benjamin, Reuben; Dolai, Tuphan Kanti; Sinha, Dinesh Kumar; Venner, Christoph... Journal: American journal of hematology Issue: Volume 96:Issue 9(2021) Page Start: 1120 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
64. Selinexor, selective inhibitor of nuclear export: Unselective bullet for blood cancers. (March 2021) Authors: Benkova, Katerina; Mihalyova, Jana; Hajek, Roman; Jelinek, Tomas Journal: Blood reviews Issue: Volume 46(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
65. Shared structural features of the 9aaTAD family in complex with CBP1. Issue 3 (17th March 2015) Authors: Piskacek, Martin; Vasku, Anna; Hajek, Roman; Knight, Andrea Journal: Molecular bioSystems Issue: Volume 11:Issue 3(2015:Mar.) Page Start: 844 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
66. Single‐agent venetoclax induces MRD‐negative response in relapsed primary plasma cell leukemia with t(11;14). Issue 1 (25th November 2018) Authors: Jelinek, Tomas; Mihalyova, Jana; Kascak, Michal; Duras, Juraj; Popkova, Tereza; Benkova, Katerina; Richterova, Petra; Plonkova, Hana; Zuchnicka, Jana; Broskevicova, Lucie; Huvarova, Lucie; Cerna, Lucie; Growkova, Katerina; Simicek, Michal; Havel, Martin; Gumulec, Jaromir; Navratil, Milan; Koriste... Journal: American journal of hematology Issue: Volume 94:Issue 1(2019:Jan.) Page Start: E35 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
67. Subgroup analysis based on cytogenetic risk in patients with relapsed or refractory multiple myeloma in the CANDOR study. (24th May 2022) Authors: Landgren, Ola; Weisel, Katja; Rosinol, Laura; Touzeau, Cyrille; Turgut, Mehmet; Hajek, Roman; Mollee, Peter; Kim, Jin Seok; Shu, Natalie; Hu, Xuguang; Li, Chuang; Usmani, Saad Z. Journal: British journal of haematology Issue: Volume 198:Number 6(2022) Page Start: 988 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
68. The role of histone deacetylase inhibitors in patients with relapsed/refractory multiple myeloma. Issue 1 (January 2014) Authors: Hajek, Roman; Siegel, David; Orlowski, Robert Z.; Ludwig, Heinz; Palumbo, Antonio; Dimopoulos, Meletios Journal: Leukemia & lymphoma Issue: Volume 55:Issue 1(2014:Jan.) Page Start: 11 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
69. The start of a new wave: Developments in proteasome inhibition in multiple myeloma. (2nd May 2018) Authors: Yong, Kwee; Gonzalez‐McQuire, Sebastian; Szabo, Zsolt; Schoen, Paul; Hajek, Roman Journal: European journal of haematology Issue: Volume 101:Number 2(2018) Page Start: 220 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
70. Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group. Issue 3 (March 2021) Authors: Moreau, Philippe; Kumar, Shaji K; San Miguel, Jesús; Davies, Faith; Zamagni, Elena; Bahlis, Nizar; Ludwig, Heinz; Mikhael, Joseph; Terpos, Evangelos; Schjesvold, Fredrik; Martin, Thomas; Yong, Kwee; Durie, Brian G M; Facon, Thierry; Jurczyszyn, Artur; Sidana, Surbhi; Raje, Noopur; van de Donk, Ni... Journal: Lancet oncology Issue: Volume 22:Issue 3(2021) Page Start: e105 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗